Robert Šeparović
orcid.org/0000-0002-4002-2699
; Department of Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Tajana Silovski
; Department of Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Robert Zorica
; Department of Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Mirjana Pavlović
; Department of Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Ljubica Vazdar
; Department of Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Vesna Pavlica
; Hospital Pharmacy, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
APA 6th Edition Šeparović, R., Silovski, T., Zorica, R., Pavlović, M., Vazdar, Lj. i Pavlica, V. (2014). Systemic therapy of early breast cancer. Libri Oncologici, 42 (1-3), 41-50. Preuzeto s https://hrcak.srce.hr/199077
MLA 8th Edition Šeparović, Robert, et al. "Systemic therapy of early breast cancer." Libri Oncologici, vol. 42, br. 1-3, 2014, str. 41-50. https://hrcak.srce.hr/199077. Citirano 26.01.2021.
Chicago 17th Edition Šeparović, Robert, Tajana Silovski, Robert Zorica, Mirjana Pavlović, Ljubica Vazdar i Vesna Pavlica. "Systemic therapy of early breast cancer." Libri Oncologici 42, br. 1-3 (2014): 41-50. https://hrcak.srce.hr/199077
Harvard Šeparović, R., et al. (2014). 'Systemic therapy of early breast cancer', Libri Oncologici, 42(1-3), str. 41-50. Preuzeto s: https://hrcak.srce.hr/199077 (Datum pristupa: 26.01.2021.)
Vancouver Šeparović R, Silovski T, Zorica R, Pavlović M, Vazdar Lj, Pavlica V. Systemic therapy of early breast cancer. Libri Oncologici [Internet]. 2014 [pristupljeno 26.01.2021.];42(1-3):41-50. Dostupno na: https://hrcak.srce.hr/199077
IEEE R. Šeparović, T. Silovski, R. Zorica, M. Pavlović, Lj. Vazdar i V. Pavlica, "Systemic therapy of early breast cancer", Libri Oncologici, vol.42, br. 1-3, str. 41-50, 2014. [Online]. Dostupno na: https://hrcak.srce.hr/199077. [Citirano: 26.01.2021.]
Sažetak Rak dojke najčešća je zloćudna bolest u žena, potencijalno izlječiva u ranom stadiju. Sustavno adjuvantno liječenje osmišljeno je za uništenje mogućih mikrometastaza proširenih iz dojke i/ili iz regionalnih limfnih čvorova, koje još nisu stvorile vidljive udaljene metastaze. Temelji se na kemoterapiji sa ili bez ciljane biološke terapije, na endokrinoj terapiji,
ponekad u kombinaciji sa zračenjem, obično nakon kirurškog zahvata. Cilj je smanjiti stopu povratka bolesti i produžiti život bolesnika.